title: [Withdrawal of an advertising campaign to promote the quadrivalent human papilloma virus vaccine in Spain].
abstract: The inclusion of the quadrivalent human papilloma virus (HPV) vaccine in the schedule of the Spanish National Health System sparked the debate over Gardasil, which was presented to the public as a "vaccine against cervical cancer". In this context, Sanofi Pasteur MSD was sued for misleading advertising in the campaign "cuentaselo.org". Although the complaint was not admitted, the lawsuit triggered five changes in the ownership of the web domain which, although backed by scientific societies, was not supported by law. Because of the violation of the Law of the Society of Information Services, and prompted by the suspicion that the pharmaceutical company was behind these changes (as it could not advertise the product), the platform for the moratorium on the HPV vaccine filed a complaint against the Spanish Society of Gynecology and Obstetrics (whose logo appeared on the webpage) for breaching the code of advertising self-regulation. Sanofi Pasteur MSD, the advertiser which was not mentioned, "accepted the complaint and removed the webpage", thus corroborating its involvement.
authors.affiliation: Departamento de Comunicación y Psicología Social, Universidad de Alicante, España. marta.martin@ua.es
authors.forename: Marta
authors.initials: M
authors.lastname: Martín-Llaguno
authors.forename: Carlos
authors.initials: C
authors.lastname: Alvarez-Dardet
mesh_terms: D000329:Advertising / Q000941:ethics / Q000331:legislation & jurisprudence*; D008192:Deception; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D005260:Female; D006176:Gynecology; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D020407:Internet / Q000331:legislation & jurisprudence; D040541:Marketing / Q000941:ethics / Q000331:legislation & jurisprudence; D053918:Papillomavirus Vaccines; D011639:Public Opinion; D012955:Societies, Medical / Q000331:legislation & jurisprudence*; D013030:Spain; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines